vix.ing · top · new · best · stats · spec

Acute kidney injury and chronic kidney disease in individuals with Down syndrome: a nationwide cohort study

2025/12/22 by Freja Leonore Uhd Weldingh, Morten Krogh Herlin, Ellen Hollands Steffensen +3 · 1 voice
Biochemistry, Genetics and Molecular Biology · Medicine · #Chronic Kidney Disease and Diabetes #Down syndrome and intellectual disability research #Genomics and Rare Diseases

paper · pdf · doi:10.1093/ckj/sfaf402

openalex publication_date 2025/12/22 · openalex created_date 2025/12/23 · openalex updated_date 2026/08/01

Abstract

Background: It is unclear whether individuals with Down syndrome (DS) are at increased risk of kidney disease. This study aims to examine the risk of acute kidney injury (AKI) and chronic kidney disease (CKD) in individuals with DS compared with the general population. Methods: Using the Danish Cytogenetic Central Registry, we identified a population-based cohort of individuals with genetically confirmed DS in Denmark between 1961 and 2021. For each individual with DS, we sampled 10 age- and sex-matched individuals without DS from the general Danish population. We used laboratory data on plasma creatinine from the 1990s until 2024 to assess AKI and CKD and computed the cumulative incidence (risk) of AKI and CKD by age. Furthermore, we estimated the risk of AKI and CKD in individuals without congenital heart disease (CHD). Results: We identified 2815 individuals with DS and available laboratory data on plasma creatinine measurements. Comparing individuals with DS to the matched cohort, the risk of AKI was 28.9% vs 1.4% at age 20, 32.8% vs 5.3% at age 40 years, and 48.6% vs 23.8% at age 70 years. The risk of CKD was 1.2% vs 0.1% at age 20, 3.9% vs 0.4% at age 40 years, and 23.2% vs 13.8% at age 70 years. For individuals without CHD, the risk of AKI and CKD remained considerably higher for individuals with DS than for matched individuals. Conclusions: Individuals with DS were at increased risk of both AKI and CKD compared with the general population. Kidney disease should be considered during clinical follow-up of DS.

Citations

Discussions

Related